|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-11-25 |
$8.37 |
0.0% |
4,600
|
$38,502 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-11-07 |
$8.43 |
0.0% |
10,600
|
$89,358 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-10-31 |
$9.26 |
0.0% |
2,300
|
$21,298 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-04-25 |
$9.88 |
0.0% |
3,600
|
$35,568 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-04-17 |
$8.98 |
0.0% |
5,400
|
$48,492 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-04-07 |
$9.10 |
0.0% |
3,600
|
$32,760 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-04-04 |
$8.73 |
0.0% |
5,500
|
$48,015 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-01-10 |
$12.51 |
0.0% |
2,500
|
$31,275 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-01-07 |
$13.58 |
0.0% |
2,900
|
$39,391 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-01-03 |
$12.95 |
0.0% |
3,400
|
$44,030 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2025-01-02 |
$11.97 |
0.0% |
2,000
|
$23,940 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-12-31 |
$11.36 |
0.0% |
2,400
|
$27,264 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-12-30 |
$11.12 |
0.0% |
3,200
|
$35,584 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-11-21 |
$12.91 |
0.0% |
1,000
|
$12,910 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-09-26 |
$14.63 |
0.0% |
1,500
|
$21,945 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-08-12 |
$13.85 |
0.0% |
800
|
$11,080 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-08-06 |
$13.81 |
-3.2% |
2,000
|
$27,620 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-08-05 |
$13.18 |
1.4% |
5,500
|
$72,490 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-08-02 |
$15.15 |
-11.7% |
1,000
|
$15,150 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-07-23 |
$15.89 |
-15.9% |
1,500
|
$23,835 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-07-18 |
$16.00 |
-16.4% |
1,000
|
$16,000 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-06-13 |
$14.30 |
-6.5% |
174,825
|
$2,499,998 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-04-01 |
$19.08 |
-29.9% |
3,000
|
$57,240 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-03-22 |
$19.98 |
-33.1% |
2,500
|
$49,950 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-03-20 |
$17.68 |
-24.4% |
1,500
|
$26,520 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-03-05 |
$12.49 |
7.0% |
30,500
|
$380,945 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-03-04 |
$13.03 |
2.6% |
4,100
|
$53,423 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-02-16 |
$11.16 |
19.8% |
10,800
|
$120,528 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2024-02-15 |
$11.07 |
20.8% |
12,700
|
$140,589 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-11-10 |
$10.17 |
31.5% |
5,000
|
$50,838 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-11-03 |
$9.11 |
46.8% |
3,500
|
$31,885 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-10-27 |
$8.57 |
56.0% |
500
|
$4,285 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-10-26 |
$7.97 |
67.8% |
2,500
|
$19,925 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-10-25 |
$7.91 |
69.0% |
2,500
|
$19,775 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-10-10 |
$9.07 |
47.4% |
1,000
|
$9,070 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-10-04 |
$8.63 |
54.9% |
2,000
|
$17,260 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-09-26 |
$8.71 |
53.5% |
600
|
$5,226 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-09-19 |
$8.95 |
49.4% |
4,000
|
$35,800 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-09-11 |
$9.48 |
41.0% |
1,000
|
$9,480 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-08-22 |
$9.97 |
34.1% |
1,000
|
$9,970 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-08-04 |
$10.55 |
26.7% |
2,000
|
$21,100 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-07-21 |
$9.20 |
45.3% |
1,000
|
$9,200 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-07-13 |
$9.49 |
40.9% |
250
|
$2,372 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-05-17 |
$11.69 |
14.4% |
1,000
|
$11,690 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-04-28 |
$11.22 |
19.2% |
250
|
$2,805 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-04-19 |
$11.10 |
20.5% |
7,000
|
$77,700 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-04-18 |
$11.12 |
20.2% |
2,000
|
$22,240 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-04-11 |
$12.42 |
7.6% |
5,000
|
$62,100 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-04-11 |
$11.87 |
12.6% |
1,000
|
$11,870 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-03-15 |
$12.71 |
5.2% |
250
|
$3,178 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-03-10 |
$12.12 |
10.3% |
1,000
|
$12,120 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-02-24 |
$15.39 |
-13.2% |
250
|
$3,849 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-02-17 |
$16.53 |
-19.1% |
600
|
$9,918 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-02-10 |
$18.68 |
-28.4% |
1,000
|
$18,680 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-02-03 |
$20.84 |
-35.8% |
250
|
$5,210 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-01-27 |
$19.20 |
-30.4% |
250
|
$4,800 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-01-27 |
$19.35 |
-30.9% |
2,000
|
$38,700 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-01-20 |
$17.37 |
-23.0% |
1,500
|
$26,055 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-01-13 |
$16.50 |
-19.0% |
250
|
$4,125 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2023-01-06 |
$15.18 |
-11.9% |
1,500
|
$22,770 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-29 |
$15.19 |
-12.0% |
4,000
|
$60,760 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-16 |
$12.94 |
3.3% |
250
|
$3,235 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-16 |
$13.01 |
2.8% |
1,000
|
$13,010 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-09 |
$13.11 |
2.0% |
2,000
|
$26,220 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-02 |
$13.98 |
-4.4% |
250
|
$3,495 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-12-02 |
$13.84 |
-3.4% |
1,000
|
$13,840 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-11-02 |
$8.79 |
52.1% |
2,000
|
$17,580 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-10-14 |
$9.75 |
37.1% |
3,000
|
$29,250 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-10-07 |
$9.72 |
37.6% |
2,000
|
$19,440 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-09-30 |
$9.46 |
41.3% |
1,000
|
$9,460 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-09-29 |
$9.23 |
44.9% |
1,000
|
$9,230 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-24 |
$9.13 |
46.4% |
29,000
|
$264,770 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-16 |
$7.13 |
87.5% |
8,000
|
$57,040 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-14 |
$7.91 |
69.0% |
12,000
|
$94,920 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-10 |
$8.33 |
60.5% |
12,000
|
$99,960 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-09 |
$10.90 |
22.7% |
4,500
|
$49,050 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-07 |
$8.55 |
56.4% |
6,000
|
$51,300 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-03 |
$8.35 |
60.1% |
9,250
|
$77,238 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-06-02 |
$7.38 |
81.2% |
6,774
|
$49,992 |
|
Daugherty Frank Joseph
|
Chief Medical Officer |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-04-25 |
$16.25 |
-17.7% |
1,000
|
$16,250 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-04-21 |
$16.09 |
-16.9% |
6,000
|
$96,540 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-04-19 |
$16.74 |
-20.1% |
6,000
|
$100,440 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-04-19 |
$16.74 |
-20.1% |
500
|
$8,370 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-02-11 |
$19.80 |
-32.5% |
5,500
|
$108,900 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-02-04 |
$19.59 |
-31.8% |
5,000
|
$97,950 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-31 |
$18.47 |
-27.6% |
500
|
$9,235 |
|
Thompson Jaye
|
VP Clinical Reg Affairs |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-21 |
$16.33 |
-18.1% |
500
|
$8,165 |
|
Hallock Kenneth
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-21 |
$16.32 |
-18.1% |
300
|
$4,896 |
|
Thompson Jaye
|
VP Clinical Reg |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-18 |
$18.87 |
-29.1% |
500
|
$9,435 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-13 |
$19.99 |
-33.1% |
1,000
|
$19,990 |
|
Thompson Jaye
|
VP Clinical Reg |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-13 |
$19.99 |
-33.1% |
1,000
|
$19,990 |
|
Daugherty Frank Joseph
|
Chief Medical Officer |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-13 |
$19.99 |
-33.1% |
1,000
|
$19,990 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2022-01-03 |
$23.82 |
-43.9% |
2,050
|
$48,831 |
|
Mcwilliams David
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2021-12-14 |
$27.56 |
-51.5% |
200
|
$5,512 |
|
Daugherty Frank Joseph
|
Chief Medical Officer |
Greenwich LifeSciences, Inc. (GLSI)
|
2021-12-14 |
$26.99 |
-50.5% |
1,111
|
$29,983 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2021-12-14 |
$27.17 |
-50.8% |
1,840
|
$49,992 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2021-04-13 |
$36.98 |
-63.8% |
2,700
|
$99,853 |
|
Hallock Kenneth
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-24 |
$5.39 |
148.2% |
1,000
|
$5,386 |
|
Daugherty Frank Joseph
|
Chief Medical Officer |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-23 |
$5.10 |
162.2% |
1,000
|
$5,100 |
|
Rothe Eric
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-20 |
$5.40 |
147.6% |
2,000
|
$10,800 |
|
Hallock Kenneth
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-20 |
$5.37 |
149.0% |
1,000
|
$5,370 |
|
Mcwilliams David
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-20 |
$5.40 |
147.6% |
1,500
|
$8,100 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-11-19 |
$5.40 |
147.7% |
2,000
|
$10,795 |
|
Mcwilliams David
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$5.75 |
132.5% |
2,608
|
$14,996 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$4.60 |
190.5% |
16,667
|
$76,710 |
|
Patel Snehal
|
CEO and CFO |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$5.75 |
132.5% |
114,347
|
$657,495 |
|
Hallock Kenneth
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$4.60 |
190.5% |
8,333
|
$38,353 |
|
Hallock Kenneth
|
Non-Executive Director |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$5.75 |
132.5% |
74,782
|
$429,996 |
|
Daugherty Frank Joseph
|
Chief Medical Officer |
Greenwich LifeSciences, Inc. (GLSI)
|
2020-09-29 |
$5.75 |
132.5% |
1,739
|
$9,999 |